Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of the American Academy of Child and Adolescent Psychiatry

• Publication date

  2017-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jaac.2017.04.005PMID 28647012PMCID PMC12925823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced Short Interval Cortical Inhibition Correlates With Atomoxetine Response in Children With Attention-Deficit Hyperactivity Disorder (ADHD)

  2014cited by this paper
• Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder

  2013cited by this paper
• Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity Disorder

  2012cited by this paper
• Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.

  2012cited by this paper
• The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.

  2011cited by this paper
• The search for biomarkers for attention deficit/hyperactivity disorder.

  2010cited by this paper
• Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.

  2009cited by this paper
• Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.

  2009cited by this paper
• Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

  2008cited by this paper
• ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD.

  2007cited by this paper
• Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison Trial

  2007cited by this paper
• Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder

  2006cited by this paper
• Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2

  2006cited by this paper
• Permutation test for periodicity in short time series data

  2006cited by this paper
• Motion correction and the use of motion covariates in multiple‐subject fMRI analysis

  2006cited by this paper
• Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study

  2005cited by this paper
• Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD

  2005cited by this paper
• Nonstationary cluster-size inference with random field and permutation methods

  2004cited by this paper
• A sensory signature that distinguishes true from false memories

  2004cited by this paper
• An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

  2003cited by this paper
• Differential patterns of striatal activation in young children with and without ADHD.

  2003cited by this paper
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

  2002cited by this paper
• Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization

  2001cited by this paper
• Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment

  2000cited by this paper
• Calculation of signal detection theory measures

  1999cited by this paper
• Event-related fMRI: characterizing differential responses.

  1998cited by this paper
• Adhd Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

  1998cited by this paper
• Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

  1997cited by this paper
• Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters.

  1996cited by this paper
• Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

  1993cited by this paper
• An assessment of clinically useful measures of the consequences of treatment.

  1988cited by this paper

• Validating molecular target-enriched fMRI for disentangling drug effects on dopamine

  2025cites this paper
• Advances in magnetic resonance imaging of the developing brain and its applications in pediatrics

  2025cites this paper
• Neural basis for individual differences in the attention-enhancing effects of methylphenidate

  2025cites this paper
• Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology

  2025cites this paper
• Neural and Cognitive Predictors of Stimulant Treatment Efficacy in Medication-Naïve ADHD Adults: A Pilot Diffusion Tensor Imaging Study

  2024cites this paper
• Catecholaminergic Modulation of Large‐Scale Network Dynamics Is Tied to the Reconfiguration of Corticostriatal Connectivity

  2024cites this paper
• Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: a comparative neuroimaging analysis

  2024cites this paper
• Translating Decades of Neuroscience Research into Diagnostic and Treatment Biomarkers for ADHD.

  2024cites this paper
• FROM NEURONS TO BRAIN NETWORKS, PHARMACODYNAMICS OF STIMULANT MEDICATION FOR ADHD.

  2024cites this paper
• Neuropsychological correlates of ADHD: indicators of different attentional profiles among youth with sluggish cognitive tempo

  2023cites this paper
• Long-term treatment of adult ADHD in a naturalistic setting: Clinical predictors of attrition, medication choice, improvement, and response

  2023cites this paper
• Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

  2022cites this paper
• Toward Precision Medicine in ADHD

  2022influential citation
• Treatment biomarkers for ADHD: Taking stock and moving forward

  2022influential citation
• Therapeutic Approaches for ADHD by Developmental Stage and Clinical Presentation

  2022cites this paper
• Caudate and cerebellar involvement in altered P2 and P3 components of GO/NoGO evoked potentials in children with attention‐deficit/hyperactivity disorder

  2021cites this paper
• Structural brain network topology underpinning ADHD and response to methylphenidate treatment

  2021cites this paper
• Responsivity of the striatal dopamine system to methylphenidate - a within-subject I-123-β-CIT-SPECT study in children and adolescents with Attention-Deficit/Hyperactivity Disorder

  2021cites this paper
• Task-Based Functional Connectivity in Attention-Deficit/Hyperactivity Disorder: A Systematic Review

  2021cites this paper
• Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients

  2021cites this paper
• Noninvasive Methodology (NMR)

  2020cites this paper
• When Helping is Risky: The Behavioral and Neurobiological Tradeoff of Social and Risk Preferences

  2020cites this paper
• Localising movement disorders in childhood.

  2019cites this paper
• The norepinephrine transporter gene modulates intrinsic brain activity, visual memory, and visual attention in children with attention-deficit/hyperactivity disorder

  2019cites this paper
• Role of homeostatic feedback mechanisms in modulating methylphenidate actions on phasic dopamine signaling in the striatum of awake behaving rats.

  2019cites this paper
• Atomoxetina no Tratamento da Perturbação da Hiperatividade - Défice de Atenção: Casuística de um Hospital Terciário Português

  2018cites this paper
• Noninvasive Methodology ( NMR )

  2018cites this paper
• Hats Off: Journal Awards 2018

  2018cites this paper
• Tourette syndrome research highlights from 2017

  2018cites this paper
• Individual Variability and Medications to Treat Attention-Deficit/Hyperactivity Disorder: The World According to the Caudate.

  2017cites this paper